Travere Therapeutics Inc Cash Flow Quality Index
Travere Therapeutics Inc cash flow quality index. Travere Therapeutics Inc (TVTX) has a Cash Flow Quality Index of 0.56x as of September 2025. Operating cash flow of $14.32 Million is below net income of $25.71 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Travere Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Travere Therapeutics Inc (2015–2015)
Cash flow quality index of Travere Therapeutics Inc from 2015 to 2015. Historical Cash Flow Quality Index for Travere Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Travere Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Travere Therapeutics Inc Cash Flow Quality Index by Year (2015–2015)
Travere Therapeutics Inc cash flow quality index by year from 2015 to 2015. Year-by-year earnings quality comparison for Travere Therapeutics Inc. For the full cash flow conversion analysis, see TVTX cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2015 | 0.00x | $-554.00K | $117.24 Million | — |